Introduction
============

Venous device systems facilitate the safe administration of cytotoxic drugs, antibiotics, blood products, fluids, and parenteral nutrition, as well as the collection of blood samples. However, their use may be associated with several complications. Implantation of these devices is occasionally associated with immediate complications such as pneumothorax and arterial or venous injury, and late complications can include infections and catheter malfunction resulting from venous thrombosis \[[@b1-kjtcv-51-333]\]. The right and left subclavian veins are the most common puncture sites. In the event of limited access to these veins, the cephalic, external jugular, brachial, and femoral veins can be used as other access points. Pinch-off syndrome (POS) occurs due to mechanical compression of the catheter between the clavicle and the first rib in subclavian vain catheterization \[[@b2-kjtcv-51-333],[@b3-kjtcv-51-333]\].

In this study, 5 patients with POS after totally implantable venous access device (TIVAD) implantation via the right subclavian vein are presented, along with a review of the relevant literature.

Methods
=======

Between January 2006 and December 2015 at the Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, 924 TIVAD implantation procedures were performed to obtain vascular access for treatment. Two Port-a-Cath systems were used (Celsite, 8.5 F; B. Braun Medical Ltd., Sheffield, UK and SlimPort, 9.6 F; Bard Access Systems, Inc., Salt Lake City, UT, USA).

All procedures were initiated from the right subclavian vein under local anesthesia. If implantation was contraindicated or impossible on the right side due to lung or breast malignancies, the left subclavian vein was used. The permanent venous catheters were implanted using the Seldinger technique, between the clavicle and the first rib, into the subclavian vein, with the cannula targeting the right atrium. After implantation, all patients underwent chest X-rays to check cannula placement and to rule out pneumothorax. All patients received prophylactic antibiotics and painkillers for a week.

Results
=======

In this study, 5 patients experienced POS after a TIVAD was implanted because of their long-term medication needs. They ranged in age from 52 to 66 years old. All 5 patients were admitted to to department of surgery, Istanbul Faculty of Medicine with symptoms of catheter occlusion or a complaint of shoulder pain. Their primary diseases, number of cannulation attempts, and the interval before complications occurred are shown in [Table 1](#t1-kjtcv-51-333){ref-type="table"}. Upon follow-up with X-ray or thoracic computed tomography (CT), catheter fracture was detected ([Figs. 1](#f1-kjtcv-51-333){ref-type="fig"}[](#f2-kjtcv-51-333){ref-type="fig"}[](#f3-kjtcv-51-333){ref-type="fig"}--[4](#f4-kjtcv-51-333){ref-type="fig"}). Segments of the cannulas were situated in the right ventricle, atrium of the heart, or superior vena cava. The transected segments were successfully removed using a loop under angiography ([Fig. 5](#f5-kjtcv-51-333){ref-type="fig"}), and the remaining parts of the catheters were also surgically removed from the body.

1) Follow-up
------------

TIVAD insertion procedures were re-performed from the left side in all cases, and no further complications occurred during follow-up. The TIVADs were re-implanted after a healing period, and the patients received their medication without any problems.

2) Literature review
--------------------

The literature review was performed using the Medline and SCOPUS databases. "Venous access device" and "POS" were used as keywords for the literature search. The initial search resulted in 12 studies about POS or complications of TIVAD.

The most common sites of catheter fragment embolization were found to be the pulmonary artery (35%), right atrium (27.6%), right ventricle (22%), and superior vena cava or peripheral veins (15.4%).

In a study involving 215 cases of catheter fracture and embolization, the clinical signs were catheter malfunction (56.3%), arrhythmias (13%), pulmonary symptoms (4.7%), and sepsis (1.8%), but 24.2% of cases were asymptomatic \[[@b3-kjtcv-51-333]\].

POS is a serious complication of TIVAD implantation. The main cause of catheter transection is POS caused by chronic compression of the connective tissue surrounding the subclavian vein between the clavicle and the first rib. In most cases, the tip of the catheter is discovered in the heart cavities or pulmonary artery. The frequency of POS has been reported as 1% in the literature \[[@b3-kjtcv-51-333]\]. The rate was 0.5% in our study.

Most catheter fragments are extracted using percutaneous intervention techniques through the femoral vein. Other systems involve multiple loops, such as the EN Snare endovascular loop system (Endovascular Snare System; Merit Medical Systems, South Jordan UT, USA), which is designed with 3 intertwined loops (made of nitinol, which confers resistance to folding and torque control) to extract foreign objects from the body and to manipulate them within the body, with a variety of sizes, ranging from 2 to 45 mm.

Twelve studies were analyzed in the final literature review, including 7 reviews, 3 randomized control trials, 1 case series, and 1 case report.

Discussion
==========

If long-term treatment such as chemotherapy is necessary, permanent implantable venous catheters are safe and more comfortable than regular venous cannulation. However, this procedure has some potential complications, such as infection, hematoma, pneumothorax, catheter embolization, and POS \[[@b3-kjtcv-51-333]\].

Intermittent compression of the catheter between the clavicle and the first rib, defined as POS, may lead to catheter obstruction and fracture. Hinke et al. \[[@b4-kjtcv-51-333]\] described 4 radiographic grades of this complication: (1) grade 0, no narrowing in the catheter's course; (2) grade 1, no luminal catheter narrowing, but deviation; (3) grade 2, luminal narrowing as the catheter passes under the clavicle (true pinch-off sign); and (4) grade 3, catheter transection.

POS can be detected in up to 1.0%--1.5% of patients after all central venous catheter implantations, and catheter dislodgement can occur in 40% of those patients \[[@b5-kjtcv-51-333]\]. To avoid POS, theoretically, a catheter must be inserted into the subclavian vein as laterally as possible \[[@b6-kjtcv-51-333]\]. In our series, POS developed in 5 of the 924 patients and radiologic evaluation revealed grade 3 POS.

Patients with POS generally present with serious pain and/or catheter obstruction. Less common symptoms include cardiac palpitations and chest or abdominal pain \[[@b7-kjtcv-51-333]\]. The occurrence of POS can occur from as early as the time of insertion to weeks, months, or years later \[[@b8-kjtcv-51-333]\]. Our patients were admitted with catheter occlusion and serious shoulder pain from 2 weeks to 14 months after implantation.

In patients with POS, thoracotomy or other surgical interventions would seriously increase morbidity and mortality. The percutaneous transvenous approach is the safest method to remove intravascular foreign bodies; it has a high success rate and has become the technique of choice since it was first described by Thomas and colleagues \[[@b7-kjtcv-51-333]--[@b11-kjtcv-51-333]\]. In our patients, the transected segment was successfully removed using a loop under angiography and the remaining part of the catheter was also removed to avoid serious embolisms. Both procedures were performed under intensive care unit conditions, and preparations were made for surgery in case of an emergency.

The use of ultrasound when inserting a venous catheter into the subclavian vein was shown to have a higher success rate with fewer complications than the landmark method in a population of patients who were critically ill \[[@b12-kjtcv-51-333]\], but ultrasound-guided puncture is not possible at many centers. A previous study used CT to reveal that the ultrasonography-guided technique tended to result in a more lateral subclavian vein approach than the landmark technique (p\<0.001), with a lower risk of POS or pneumothorax than when the landmark venipuncture technique was used \[[@b13-kjtcv-51-333]\].

In conclusion, central venous catheters are useful for patients who require long-term treatment, but complications may arise as a result of this procedure. POS should not be overlooked as a possible complication.
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![Part of a fractured catheter is seen in the heart on a computed tomography scan (arrow).](kjtcv-51-333f1){#f1-kjtcv-51-333}

![Part of a fractured catheter is seen in the superior vena cava (X-ray imaging, arrow).](kjtcv-51-333f2){#f2-kjtcv-51-333}

![Part of a fractured catheter that had migrated to the right ventricle (X-ray imaging, arrow).](kjtcv-51-333f3){#f3-kjtcv-51-333}

![Pinch-off syndrome due to chronic compression between the clavicle and the first rib (X-ray imaging, arrow).](kjtcv-51-333f4){#f4-kjtcv-51-333}

![Fractured part of a catheter removed under angiography from the right ventricle (arrow).](kjtcv-51-333f5){#f5-kjtcv-51-333}

###### 

Primary diseases, number of cannulation attempts, and the interval before complications of cases

  Serial no. of patients   Age (yr)   Primary disease   No. of puncture attempts   Localization of insertion   Localization of fractured part                                    Time to complication
  ------------------------ ---------- ----------------- -------------------------- --------------------------- ----------------------------------------------------------------- ----------------------
  1                        66         Rectal cancer     4                          Right SCV                   Right atrium ([Fig. 1](#f1-kjtcv-51-333){ref-type="fig"})         2 wk
  2                        66         Breast cancer     3                          Right SCV                   Vena cava superior ([Fig. 2](#f2-kjtcv-51-333){ref-type="fig"})   3 wk
  3                        54         Breast cancer     1                          Right SCV                   Right ventricle ([Fig. 3](#f3-kjtcv-51-333){ref-type="fig"})      6 mo
  4                        61         Colon cancer      1                          Right SCV                   Right atrium ([Fig. 4](#f4-kjtcv-51-333){ref-type="fig"})         8 mo
  5                        52         Stomach cancer    2                          Right SCV                   Right ventricle ([Fig. 5](#f5-kjtcv-51-333){ref-type="fig"})      14 mo

SVC, subclavian vein.
